Liquidia

LQDANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.946 B

$66.43 -0.67%

Close of 21 Sept 2026

Revenue

$158.3M

#2371 by revenue

Earnings

-$68.9M

Loss-making

Shares outstanding

89,508,891

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#47Kiniksa Pharmaceuticals InternationalKNSA$6.10B
#48Mirum PharmaceuticalsMIRM$5.97B
#49LiquidiaLQDA$5.95B
#50Travere TherapeuticsTVTX$5.93B
#51Ligand PharmaceuticalsLGND$5.78B

What if Liquidia were worth as much as…

Open the what-if tool →

Gold $30.3T

$338,223.99

Per share 5,091× higher

Bitcoin $1.72T

$19,213.78

Per share 289× higher

Nvidia $5.48T

$61,221.38

Per share 922× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Liquidia are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.